Annual Total Long Term Liabilities
$41.50 M
+$17.68 M+74.23%
December 31, 2024
Summary
- As of March 4, 2025, KNSA annual total long term liabilities is $41.50 million, with the most recent change of +$17.68 million (+74.23%) on December 31, 2024.
- During the last 3 years, KNSA annual total long term liabilities has risen by +$38.56 million (+1311.91%).
- KNSA annual total long term liabilities is now -65.35% below its all-time high of $119.77 million, reached on December 31, 2017.
Performance
KNSA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$41.50 M
+$19.16 M+85.77%
December 31, 2024
Summary
- As of March 4, 2025, KNSA quarterly total long term liabilities is $41.50 million, with the most recent change of +$19.16 million (+85.77%) on December 31, 2024.
- Over the past year, KNSA quarterly long term liabilities has stayed the same.
- KNSA quarterly long term liabilities is now -65.35% below its all-time high of $119.77 million, reached on December 31, 2017.
Performance
KNSA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
KNSA Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +74.2% | 0.0% |
| 3 y3 years | +1311.9% | +1311.9% |
| 5 y5 years | +3139.3% | +3139.3% |
KNSA Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1311.9% | at high | +1311.9% |
| 5 y | 5-year | at high | +3139.3% | at high | +8672.9% |
| alltime | all time | -65.3% | >+9999.0% | -65.3% | >+9999.0% |
Kiniksa Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $41.50 M(+74.2%) | $41.50 M(+85.8%) |
| Sep 2024 | - | $22.34 M(-3.1%) |
| Jun 2024 | - | $23.04 M(-2.2%) |
| Mar 2024 | - | $23.57 M(-1.1%) |
| Dec 2023 | $23.82 M(+44.7%) | $23.82 M(-2.7%) |
| Sep 2023 | - | $24.47 M(-2.9%) |
| Jun 2023 | - | $25.20 M(+55.8%) |
| Mar 2023 | - | $16.18 M(-1.7%) |
| Dec 2022 | $16.46 M(+460.0%) | $16.46 M(-15.4%) |
| Sep 2022 | - | $19.45 M(+43.7%) |
| Jun 2022 | - | $13.54 M(-5.8%) |
| Mar 2022 | - | $14.37 M(+388.8%) |
| Dec 2021 | $2.94 M | $2.94 M(-33.0%) |
| Sep 2021 | - | $4.38 M(-5.5%) |
| Jun 2021 | - | $4.64 M(-7.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $5.01 M(-11.9%) |
| Dec 2020 | $5.68 M(+343.6%) | $5.68 M(+461.6%) |
| Sep 2020 | - | $1.01 M(+114.0%) |
| Jun 2020 | - | $473.00 K(-49.2%) |
| Mar 2020 | - | $932.00 K(-27.2%) |
| Dec 2019 | $1.28 M(+789.6%) | $1.28 M(-45.1%) |
| Sep 2019 | - | $2.33 M(-15.5%) |
| Jun 2019 | - | $2.76 M(+0.5%) |
| Mar 2019 | - | $2.75 M(+1808.3%) |
| Dec 2018 | $144.00 K(-99.9%) | $144.00 K(-13.8%) |
| Sep 2018 | - | $167.00 K(-10.2%) |
| Jun 2018 | - | $186.00 K(+520.0%) |
| Mar 2018 | - | $30.00 K(-100.0%) |
| Dec 2017 | $119.77 M(+49.9%) | $119.77 M |
| Dec 2016 | $79.90 M | - |
FAQ
- What is Kiniksa Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Kiniksa Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of KNSA is $41.50 M
What is the all time high annual total long term liabilities for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual total long term liabilities is $119.77 M
What is Kiniksa Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, KNSA annual total long term liabilities has changed by +$17.68 M (+74.23%)
What is Kiniksa Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of KNSA is $41.50 M
What is the all time high quarterly long term liabilities for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly total long term liabilities is $119.77 M
What is Kiniksa Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, KNSA quarterly total long term liabilities has changed by $0.00 (0.00%)